Salix SEC Investigation

Reuters reported on Tuesday that the U.S. Securities and Exchange Commission is investigating former top executives at Salix Pharmaceuticals over allegedly misleading investors. The investigation focuses on Salix's 2014 disclosure that its drug inventory levels were higher than previously...